Age, moderate to severe MR, mean TLR2+/CD14+cells (%), TLR2+CD14+ ≥25%, TLR4+/CD14+cells ≥0.25%, mean Ly6G+/CD14+cells (%), MPO+/CD14+cells (%), MPO+/CD14+cells ≥20%, and mean sST-2 and sST2 ≥17,600 (pg/mL) were potentially predictive of moderate-severe CCS. Here, CD14 is linked to miotic rate.